Evidence map›Paper›PMID 36786950›Full record

ArticleArchives of virology2023

Evidence of natural selection and dominance of SARS-CoV-2 variant Lambda (C.37) over variants of concern in Cusco, Peru.

Maria Antonieta Quispe-Ricalde, Hugo G Castelán-Sánchez, Pablo M Meza-Rodríguez, Sonia Dávila-Ramos, José Luis Sierra, Ramón Batista-Garcia, Fátima Concha-Velasco, Sonia Flores Lucana, José De Santa Cruz, Víctor Zea and 6 more

Abstract read
In one paragraph

Article in Archives of virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Maria Antonieta Quispe-Ricalde *Departamento de Biología, Facultad de Ciencias, Universidad Nacional de San Antonio Abad del Cusco, Av. de La Cultura 733, C.P. 0800, Cusco, Perú. antonieta.quispe@unsaac.edu.pe.ORCID http://orcid.org/0000-0001-6349-1095
Hugo G Castelán-Sánchez *Programa de Investigadoras e Investigadores por México. Grupo de Genómica y Dinámica Evolutiva de Microorganismos Emergentes, Consejo Nacional de Ciencia y Tecnología, Av. Insurgentes Sur 1582, Crédito Constructo, Benito Juárez, Ciudad de México, C.P. 03940, México. hugo.castelan@conacyt.mx.
Pablo M Meza-RodríguezCentro de Investigación en Dinámica Celular, Instituto de Investigaciones en Ciencias Básicas y Aplicadas, Universidad Autónoma del Estado de Morelos, Morelos. Av. Universidad 1001. Col. Chamilpa, Cuernavaca, Morelos, C.P. 62209, México.
Sonia Dávila-RamosCentro de Investigación en Dinámica Celular, Instituto de Investigaciones en Ciencias Básicas y Aplicadas, Universidad Autónoma del Estado de Morelos, Morelos. Av. Universidad 1001. Col. Chamilpa, Cuernavaca, Morelos, C.P. 62209, México.
José Luis SierraEscuela de Postgrado, Universidad Nacional de San Antonio Abad del Cusco, Av. de La Cultura 733, Cusco, C.P. 0800, Perú.
Ramón Batista-GarciaCentro de Investigación en Dinámica Celular, Instituto de Investigaciones en Ciencias Básicas y Aplicadas, Universidad Autónoma del Estado de Morelos, Morelos. Av. Universidad 1001. Col. Chamilpa, Cuernavaca, Morelos, C.P. 62209, México.
Fátima Concha-VelascoLaboratorio Regional de Referencia, Gerencia Regional de Salud Cusco, Av. de La Cultura 147, Cusco, C.P. 08003, Perú.
Sonia Flores LucanaLaboratorio Regional de Referencia, Gerencia Regional de Salud Cusco, Av. de La Cultura 147, Cusco, C.P. 08003, Perú.
José De Santa CruzLaboratorio Regional de Referencia, Gerencia Regional de Salud Cusco, Av. de La Cultura 147, Cusco, C.P. 08003, Perú.
Víctor ZeaLaboratorio Regional de Referencia, Gerencia Regional de Salud Cusco, Av. de La Cultura 147, Cusco, C.P. 08003, Perú.
Marco GalarzaLaboratorio de Referencia Nacional de Biotecnología y Biología Molecular, Instituto Nacional de Salud, Lima, Perú.
Omar Caceres-ReyLaboratorio de Referencia Nacional de Biotecnología y Biología Molecular, Instituto Nacional de Salud, Lima, Perú.
Pablo TsukayamaLaboratorio de Genómica Microbiana, Universidad Peruana Cayetano Heredia, Av. Honorio Delgado 430, San Martín de Porres 15102, Lima, C.P. 15102, Perú.
Pilar ForondaUniversity Institute of Tropical Diseases and Public Health of the Canary Islands, Av. Astrofísico FranciscoSánchez, s/n, San Cristóbal de La Laguna, Tenerife, C.P.38200, Spain.
Brandon Jason Soto-ChambiDepartamento de Biología, Facultad de Ciencias, Universidad Nacional de San Antonio Abad del Cusco, Av. de La Cultura 733, C.P. 0800, Cusco, Perú.
Nestor AbreuUniversity Institute of Tropical Diseases and Public Health of the Canary Islands, Av. Astrofísico FranciscoSánchez, s/n, San Cristóbal de La Laguna, Tenerife, C.P.38200, Spain. nabreu@ull.edu.es.

Funding

Universidad Nacional de San Antonio Abad del Cusco R-540-2020-UNSAAC
6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage C.37 (Lambda) has spread rapidly in Peru and other Latin American countries. However, most studies in Peru have focused on Lima, the capital city, without knowing the dynamics of the spread of the variant in other departments. Cusco, Peru, is one of the most popular departments in the country for tourists, so the introduction of new variants of SARS-CoV-2 might occur despite closure of the borders. Therefore, in this work, we analyzed the variants circulating in Cusco. The aim of this work was to better understand the distribution of SARS-CoV-2 lineages circulating in Cusco and to characterize the genomes of these strains. To this end, 46 SARS-CoV-2 genomes from vaccinated and unvaccinated patients were sequenced in the first half of 2021. The genomes were analyzed using phylogenetic and natural selection methods. Phylogenetic trees from Cusco showed dominance of the Lambda lineage over the variants of concern (VOCs), and there was no clustering of variants by district. Natural selection analysis revealed mutations, mainly in the spike protein, at positions 75, 246, 247, 707, 769, and 1020. In addition, we found that unvaccinated patients accumulated more new mutations than did vaccinated patients, and these included the F101Y mutation in ORF7a, E419A in NSP3, a deletion in S (21,618-22,501), and a deletion in ORF3a (25,437-26,122).

Indexed as

COVID-19SARS-CoV-2Selection, GeneticHumansMutationPeruPhylogenySpike Glycoprotein, CoronavirusSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID36786950
PMCPMC9926449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.